125 related articles for article (PubMed ID: 36513579)
1. Silencing effects of mutant RAS signalling on transcriptomes.
Sers C; Schäfer R
Adv Biol Regul; 2023 Jan; 87():100936. PubMed ID: 36513579
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway.
Wang CH; Shyu RY; Wu CC; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM
J Biomed Sci; 2014 May; 21(1):36. PubMed ID: 24884338
[TBL] [Abstract][Full Text] [Related]
3. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
Irimia M; Fraga MF; Sanchez-Cespedes M; Esteller M
Oncogene; 2004 Nov; 23(53):8695-9. PubMed ID: 15378027
[TBL] [Abstract][Full Text] [Related]
4. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
[TBL] [Abstract][Full Text] [Related]
5. LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT.
Kaufman JM; Amann JM; Park K; Arasada RR; Li H; Shyr Y; Carbone DP
J Thorac Oncol; 2014 Jun; 9(6):794-804. PubMed ID: 24828662
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins.
Han BG; Cho JW; Cho YD; Kim SY; Yoon HJ; Song HK; Cheong HK; Jeon YH; Lee DK; Lee S; Lee BI
Protein Expr Purif; 2010 May; 71(1):103-7. PubMed ID: 20100577
[TBL] [Abstract][Full Text] [Related]
7. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Xia W; Bai H; Deng Y; Yang Y
J Cell Mol Med; 2020 Nov; 24(21):12642-12655. PubMed ID: 32985124
[TBL] [Abstract][Full Text] [Related]
8. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.
Akino K; Toyota M; Suzuki H; Mita H; Sasaki Y; Ohe-Toyota M; Issa JP; Hinoda Y; Imai K; Tokino T
Gastroenterology; 2005 Jul; 129(1):156-69. PubMed ID: 16012945
[TBL] [Abstract][Full Text] [Related]
9. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
10. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
11. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers.
Kaneda A; Wakazono K; Tsukamoto T; Watanabe N; Yagi Y; Tatematsu M; Kaminishi M; Sugimura T; Ushijima T
Cancer Res; 2004 Sep; 64(18):6410-5. PubMed ID: 15374948
[TBL] [Abstract][Full Text] [Related]
13. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
14. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
[TBL] [Abstract][Full Text] [Related]
16. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
18. An involvement of phospholipase A/acyltransferase family proteins in peroxisome regulation and plasmalogen metabolism.
Uyama T; Tsuboi K; Ueda N
FEBS Lett; 2017 Sep; 591(18):2745-2760. PubMed ID: 28796890
[TBL] [Abstract][Full Text] [Related]
19. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development.
Sharp TV; Al-Attar A; Foxler DE; Ding L; de A Vallim TQ; Zhang Y; Nijmeh HS; Webb TM; Nicholson AG; Zhang Q; Kraja A; Spendlove I; Osborne J; Mardis E; Longmore GD
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19932-7. PubMed ID: 19060205
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
